➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Moodys
Colorcon
McKinsey
Boehringer Ingelheim
AstraZeneca

Last Updated: September 27, 2020

DrugPatentWatch Database Preview

STILBESTROL Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Stilbestrol, and when can generic versions of Stilbestrol launch?

Stilbestrol is a drug marketed by Bristol Myers Squibb and Tablicaps and is included in seven NDAs.

The generic ingredient in STILBESTROL is diethylstilbestrol. There are twenty-six drug master file entries for this compound. Additional details are available on the diethylstilbestrol profile page.

Summary for STILBESTROL
Drug patent expirations by year for STILBESTROL

US Patents and Regulatory Information for STILBESTROL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb STILBESTROL diethylstilbestrol INJECTABLE;INJECTION 004056-003 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Tablicaps STILBESTROL diethylstilbestrol TABLET, DELAYED RELEASE;ORAL 083003-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Bristol Myers Squibb STILBESTROL diethylstilbestrol INJECTABLE;INJECTION 004056-006 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Tablicaps STILBESTROL diethylstilbestrol TABLET;ORAL 083006-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Tablicaps STILBESTROL diethylstilbestrol TABLET, DELAYED RELEASE;ORAL 083005-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Bristol Myers Squibb STILBESTROL diethylstilbestrol INJECTABLE;INJECTION 004056-004 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Boehringer Ingelheim
Johnson and Johnson
Express Scripts
AstraZeneca
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.